NET INCOME PER COMMON SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator [Abstract]
Net income	$ 3,839	$ 2,426	$ 4,489	$ 3,512	$ 783	$ (1,750)	$ 10,754	$ 2,545
Less: preferred stock dividend	(304)			(1,074)			(912)	(1,074)
Less: allocation to preferred stockholders	(582)			(433)			(1,629)	(259)
Less: allocation to restricted stockholders	(232)			(120)			(635)	(65)
Net income allocated to common stockholders	$ 2,721			$ 1,885			$ 7,579	$ 1,147
Denominator [Abstract]
Weighted average common shares outstanding (in shares)	25,135,381			24,821,665			25,043,357	24,720,817
Basic income per share (in dollars per share)	$ 0.11			$ 0.08			$ 0.30	$ 0.05
Denominator [Abstract]
Weighted average number of common shares outstanding (in shares)	25,135,381			24,821,665			25,043,357	24,720,817
Diluted shares outstanding (in shares)	25,135,381			24,821,665			25,043,357	24,720,817
Diluted income per share (in dollars per share)	$ 0.11			$ 0.08			$ 0.30	$ 0.05
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	6,196,739			767,056			6,205,018	566,370
Unvested Restricted Stock [Member]
Denominator [Abstract]
Dilutive potential common shares outstanding (in shares)	0			0			0	0
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	815,383			767,056			823,662	566,370
Series A Preferred Stock [Member]
Denominator [Abstract]
Dilutive potential common shares outstanding (in shares)	0			0			0	0
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	5,381,356			0			5,381,356	0